Pioglitazone use and risk of bladder cancer in patients with type 2 diabetes: retrospective cohort study using datasets from four European countries.

Korhonen, P; Heintjes, EM; Williams, R; Hoti, F; Christopher, S; Majak, M; Kool-Houweling, L; Strongman, H; Linder, M; Dolin, P; +1 more... Bahmanyar, S; (2016) Pioglitazone use and risk of bladder cancer in patients with type 2 diabetes: retrospective cohort study using datasets from four European countries. BMJ (Clinical research ed), 354. i3903. ISSN 0959-8138 DOI: https://doi.org/10.1136/bmj.i3903

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1136/bmj.i3903

Abstract

Share

Download

Filename: Pioglitazone use and risk_GOLD VoR.pdf

Licence: Creative Commons: Attribution 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar